(Q35982210)

11 August 2017

High-dose cytosine arabinoside plus etoposide as initial treatment for acute myeloid leukaemia: a single centre study (English)

1 reference

11 August 2017

1 reference

1 reference

1 reference

Parikh P

1

1 reference

11 August 2017

Powles R

2

1 reference

11 August 2017

Treleaven J

3

1 reference

11 August 2017

Helenglass G

4

1 reference

11 August 2017

Gore M

5

1 reference

11 August 2017

Rose M

6

1 reference

11 August 2017

Talbot D

7

1 reference

11 August 2017

Milan S

8

1 reference

11 August 2017

Smith C

9

1 reference

11 August 2017

Pinkerton R

10

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 November 1990

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

62

1 reference

11 August 2017

5

1 reference

11 August 2017

830-833

1 reference

Uncommon subtypes of acute nonlymphocytic leukemia: clinical features and management of FAB M5, M6 and M7.

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971542

Allogeneic and autologous bone marrow transplantation for acute nonlymphocytic leukemia.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971542

Current chemotherapeutic treatment approaches to the management of previously untreated adults with de novo acute myelogenous leukemia.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971542

Bone marrow transplantation--the Marsden experience

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971542

Etoposide (VP-16-213). Current status of an active anticancer drug

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971542

Chemotherapy of acute myeloid leukaemia (AML) in UK: past, present and future.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971542

Short-term therapy for acute myelogenous leukemia

2 October 2017

1 reference

12 December 2020

Treatment of relapsed and refractory acute leukaemia with high-dose cytosine arabinoside and etoposide

1 reference

12 December 2020

Response of L1210 to combinations of cytosine arabinoside and VM-26 or VP16-213

1 reference

12 December 2020

Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation

1 reference

12 December 2020

THE PLACE OF BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKÆMIA

1 reference

12 December 2020

VP 16-213 and cytosine-arabinoside combination chemotherapy for refractory acute lymphoblastic leukemia in adults

1 reference

12 December 2020

Prolonged unmaintained remission after intensive consolidation therapy in adult acute nonlymphocytic leukemia

1 reference

12 December 2020

Therapy of acute myelogenous leukemia

1 reference

12 December 2020

Comparison of three remission induction regimens and two postinduction strategies for the treatment of acute nonlymphocytic leukemia: a cancer and leukemia group B study

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1990.387

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference

11 August 2017

PubMed publication ID

2245176

1 reference